Increased oxidative damage and mitochondrial abnormalities in the peripheral blood of Huntington’s disease patients
- 24 May 2007
- journal article
- Published by Elsevier BV in Biochemical and Biophysical Research Communications
- Vol. 359 (2), 335-340
- https://doi.org/10.1016/j.bbrc.2007.05.093
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Huntington disease patients and transgenic mice have similar pro-catabolic serum metabolite profilesBrain, 2006
- Therapeutics development for triplet repeat expansion diseasesNature Reviews Genetics, 2005
- Adenosine A2A receptor dysfunction correlates with age at onset anticipation in blood platelets of subjects with Huntington's diseaseAmerican Journal Of Medical Genetics Part B-Neuropsychiatric Genetics, 2005
- Genome-wide expression profiling of human blood reveals biomarkers for Huntington's diseaseProceedings of the National Academy of Sciences, 2005
- Akt is altered in an animal model of Huntington's disease and in patientsEuropean Journal of Neuroscience, 2005
- Autophagosome-like vacuole formation in Huntingtonʼs disease lymphoblastsNeuroReport, 2004
- Increased apoptosis of Huntington disease lymphoblasts associated with repeat length-dependent mitochondrial depolarizationNature Medicine, 1999
- Aggregation of Huntingtin in Neuronal Intranuclear Inclusions and Dystrophic Neurites in BrainScience, 1997
- Oxidative damage and metabolic dysfunction in Huntington's disease: Selective vulnerability of the basal gangliaAnnals of Neurology, 1997
- A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomesCell, 1993